Đang chuẩn bị liên kết để tải về tài liệu:
Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: A real-world chart review study
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Daratumumab, a CD38 monoclonal antibody, has demonstrated efficacy as monotherapy and combination therapy across several indications, both among newly-diagnosed and refractory patients with multiple myeloma (MM). |